About: Dihydrotestosterone     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/drugbank/Drug, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
http://linked.open...gbank/description
  • A potent androgenic metabolite of testosterone. Dihydrotestosterone (DHT) is generated by a 5-alpha reduction of testosterone. Unlike testosterone, DHT cannot be aromatized to estradiol therefore DHT is considered a pure androgenic steroid. [PubChem] (en)
http://linked.open...gy/drugbank/group
  • experimental (en)
  • illicit (en)
sameAs
Title
  • Dihydrotestosterone (en)
adms:identifier
http://linked.open.../drugbank/synonym
  • Androstanolone (en)
  • (5a,17b)-17-Hydroxyandrostan-3-one (en)
  • (5alpha,17beta)-17-hydroxyandrostan-3-one (en)
  • 17beta-Hydroxy-5alpha-androstan-3-one (en)
  • 17beta-Hydroxy-5alpha-androstane-3-one (en)
  • 17beta-Hydroxyandrostan-3-one (en)
  • 4-Dihydrotestosterone (en)
  • 5.alpha.-Dihydrotestosterone (en)
  • 5a-Dihydrotestosterone (en)
  • 5alpha dihydrotestosterone (en)
  • 5alpha-Dihydrotestosterone (en)
  • Anaboleen (en)
  • Androlone (en)
  • Androstan-17b-ol-3-one (en)
  • Androstan-17beta-ol-3-one (en)
  • Stanaprol (en)
  • Stanolone (en)
http://linked.open...drugbank/toxicity
  • Oral LD<sub>50</sub> in rat is 7060 mg/kg. Oral LD<sub>50</sub> in mouse is 3450 mg/kg. (en)
http://linked.open...ynthesisReference
  • A. Glenn Braswell, Aftab J. Ahmed, "Composition for inhibiting production of dihydrotestosterone to treat benign prostate hyperplasia." U.S. Patent US6264996, issued October, 1996. (en)
http://linked.open...ugbank/IUPAC-Name
http://linked.open...gy/drugbank/InChI
http://linked.open...Molecular-Formula
http://linked.open.../Molecular-Weight
http://linked.open...noisotopic-Weight
http://linked.open...y/drugbank/SMILES
http://linked.open.../Water-Solubility
http://linked.open...ogy/drugbank/logP
http://linked.open...ogy/drugbank/logS
http://linked.open...nd-Acceptor-Count
http://linked.open...-Bond-Donor-Count
http://linked.open...drugbank/InChIKey
http://linked.open...urface-Area--PSA-
http://linked.open...nk/Polarizability
http://linked.open...bank/Refractivity
http://linked.open...atable-Bond-Count
http://linked.open...ugbank/absorption
  • Bioavailability is very low (0-2%) following oral administration. (en)
http://linked.open.../affectedOrganism
  • Humans and other mammals (en)
http://linked.open...casRegistryNumber
  • 521-18-6 (en)
http://linked.open...drugbank/category
  • (en)
http://linked.open...k/Bioavailability
http://linked.open...bank/Ghose-Filter
http://linked.open...nk/MDDR-Like-Rule
http://linked.open...ank/Melting-Point
http://linked.open...k/Number-of-Rings
http://linked.open...siological-Charge
http://linked.open...bank/Rule-of-Five
http://linked.open...tional-IUPAC-Name
http://linked.open...strongest-acidic-
http://linked.open...-strongest-basic-
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 46 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software